215 related articles for article (PubMed ID: 19503602)
1. Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways.
Rittirsch D; Flierl MA; Day DE; Nadeau BA; Zetoune FS; Sarma JV; Werner CM; Wanner GA; Simmen HP; Huber-Lang MS; Ward PA
PLoS Pathog; 2009 Jun; 5(6):e1000464. PubMed ID: 19503602
[TBL] [Abstract][Full Text] [Related]
2. Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation.
Skokowa J; Ali SR; Felda O; Kumar V; Konrad S; Shushakova N; Schmidt RE; Piekorz RP; Nürnberg B; Spicher K; Birnbaumer L; Zwirner J; Claassens JW; Verbeek JS; van Rooijen N; Köhl J; Gessner JE
J Immunol; 2005 Mar; 174(5):3041-50. PubMed ID: 15728518
[TBL] [Abstract][Full Text] [Related]
3. THP-1 cells increase TNF-α production upon LPS + soluble human IgG co-stimulation supporting evidence for TLR4 and Fcγ receptors crosstalk.
Vargas-Hernández O; Ventura-Gallegos JL; Ventura-Ayala ML; Torres M; Zentella A; Pedraza-Sánchez S
Cell Immunol; 2020 Sep; 355():104146. PubMed ID: 32702524
[TBL] [Abstract][Full Text] [Related]
4. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a.
Syed SN; Konrad S; Wiege K; Nieswandt B; Nimmerjahn F; Schmidt RE; Gessner JE
Eur J Immunol; 2009 Dec; 39(12):3343-56. PubMed ID: 19795417
[TBL] [Abstract][Full Text] [Related]
5. TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2.
Raby AC; Holst B; Davies J; Colmont C; Laumonnier Y; Coles B; Shah S; Hall J; Topley N; Köhl J; Morgan BP; Labéta MO
Eur J Immunol; 2011 Sep; 41(9):2741-52. PubMed ID: 21630250
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor type-1 deficiency exaggerates LPS-induced acute lung injury through enhancing Toll-like receptor 4 signaling pathway.
Hua F; Ren W; Zhu L
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):480-6. PubMed ID: 21577093
[TBL] [Abstract][Full Text] [Related]
7. Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4.
Mancuso G; Midiri A; Biondo C; Beninati C; Gambuzza M; Macrì D; Bellantoni A; Weintraub A; Espevik T; Teti G
Infect Immun; 2005 Sep; 73(9):5620-7. PubMed ID: 16113279
[TBL] [Abstract][Full Text] [Related]
8. FcRγ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway.
Wei ZM; Wang Z; Wan XJ; Li XJ; Li YX; Bai Y; Yang X; Yang Y; Jiao SC; Liu ZF
Immunol Res; 2019 Feb; 67(1):77-83. PubMed ID: 30552619
[TBL] [Abstract][Full Text] [Related]
9. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.
Shushakova N; Skokowa J; Schulman J; Baumann U; Zwirner J; Schmidt RE; Gessner JE
J Clin Invest; 2002 Dec; 110(12):1823-30. PubMed ID: 12488432
[TBL] [Abstract][Full Text] [Related]
10. Silencing Bruton's tyrosine kinase in alveolar neutrophils protects mice from LPS/immune complex-induced acute lung injury.
Krupa A; Fol M; Rahman M; Stokes KY; Florence JM; Leskov IL; Khoretonenko MV; Matthay MA; Liu KD; Calfee CS; Tvinnereim A; Rosenfield GR; Kurdowska AK
Am J Physiol Lung Cell Mol Physiol; 2014 Sep; 307(6):L435-48. PubMed ID: 25085625
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory action of Athyrium multidentatum extract suppresses the LPS-induced TLR4 signaling pathway.
Han XZ; Ma R; Chen Q; Jin X; Jin YZ; An RB; Piao XM; Lian ML; Quan LH; Jiang J
J Ethnopharmacol; 2018 May; 217():220-227. PubMed ID: 29476961
[TBL] [Abstract][Full Text] [Related]
13. TLR5 participates in the TLR4 receptor complex and promotes MyD88-dependent signaling in environmental lung injury.
Hussain S; Johnson CG; Sciurba J; Meng X; Stober VP; Liu C; Cyphert-Daly JM; Bulek K; Qian W; Solis A; Sakamachi Y; Trempus CS; Aloor JJ; Gowdy KM; Foster WM; Hollingsworth JW; Tighe RM; Li X; Fessler MB; Garantziotis S
Elife; 2020 Jan; 9():. PubMed ID: 31989925
[TBL] [Abstract][Full Text] [Related]
14. Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27(p28) from macrophages.
Bosmann M; Haggadone MD; Hemmila MR; Zetoune FS; Sarma JV; Ward PA
J Immunol; 2012 May; 188(10):5086-93. PubMed ID: 22491257
[TBL] [Abstract][Full Text] [Related]
15. The inositol 3-phosphatase PTEN negatively regulates Fc gamma receptor signaling, but supports Toll-like receptor 4 signaling in murine peritoneal macrophages.
Cao X; Wei G; Fang H; Guo J; Weinstein M; Marsh CB; Ostrowski MC; Tridandapani S
J Immunol; 2004 Apr; 172(8):4851-7. PubMed ID: 15067063
[TBL] [Abstract][Full Text] [Related]
16. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
17. Dioscin alleviates lipopolysaccharide-induced acute lung injury through suppression of TLR4 signaling pathways.
Wang C; Li Q; Li T
Exp Lung Res; 2020; 46(1-2):11-22. PubMed ID: 31931639
[No Abstract] [Full Text] [Related]
18. Sevoflurane inhibits nuclear factor-κB activation in lipopolysaccharide-induced acute inflammatory lung injury via toll-like receptor 4 signaling.
Sun XJ; Li XQ; Wang XL; Tan WF; Wang JK
PLoS One; 2015; 10(4):e0122752. PubMed ID: 25875290
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
[TBL] [Abstract][Full Text] [Related]
20. LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway.
He HQ; Wu YX; Nie YJ; Wang J; Ge M; Qian F
Acta Pharmacol Sin; 2017 Mar; 38(3):342-350. PubMed ID: 28112185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
